These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 7609060)

  • 1. Picornavirus-specific CD4+ T lymphocytes possessing cytolytic activity confer protection in the absence of prophylactic antibodies.
    Neal ZC; Splitter GA
    J Virol; 1995 Aug; 69(8):4914-23. PubMed ID: 7609060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against lethal encephalomyocarditis virus infection in the absence of serum-neutralizing antibodies.
    Neal ZC; Splitter GA
    J Virol; 1998 Oct; 72(10):8052-60. PubMed ID: 9733845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor.
    Mahon BP; Katrak K; Nomoto A; Macadam AJ; Minor PD; Mills KH
    J Exp Med; 1995 Apr; 181(4):1285-92. PubMed ID: 7699320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of adult but not newborn mice against lethal intracerebral challenge with Japanese encephalitis virus by adoptively transferred virus-specific cytotoxic T lymphocytes: requirement for L3T4+ T cells.
    Murali-Krishna K; Ravi V; Manjunath R
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():705-14. PubMed ID: 8627259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA; Knipe DM
    Virology; 1997 Dec; 239(2):315-26. PubMed ID: 9434723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
    Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
    J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine-induced protection against orthopoxvirus infection is mediated through the combined functions of CD4 T cell-dependent antibody and CD8 T cell responses.
    Chaudhri G; Tahiliani V; Eldi P; Karupiah G
    J Virol; 2015 Feb; 89(3):1889-99. PubMed ID: 25428875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge.
    Epstein SL; Stack A; Misplon JA; Lo CY; Mostowski H; Bennink J; Subbarao K
    Int Immunol; 2000 Jan; 12(1):91-101. PubMed ID: 10607754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of virus-specific CD4+ cytotoxic T cells in recovery from mouse hepatitis virus infection.
    Wijburg OL; Heemskerk MH; Sanders A; Boog CJ; Van Rooijen N
    Immunology; 1996 Jan; 87(1):34-41. PubMed ID: 8666433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
    Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
    Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires CD4(+) T cells.
    Rao M; Bray M; Alving CR; Jahrling P; Matyas GR
    J Virol; 2002 Sep; 76(18):9176-85. PubMed ID: 12186901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells.
    Connors M; Kulkarni AB; Firestone CY; Holmes KL; Morse HC; Sotnikov AV; Murphy BR
    J Virol; 1992 Dec; 66(12):7444-51. PubMed ID: 1433525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecularly engineered vaccine which expresses an immunodominant T-cell epitope induces cytotoxic T lymphocytes that confer protection from lethal virus infection.
    Klavinskis LS; Whitton JL; Oldstone MB
    J Virol; 1989 Oct; 63(10):4311-6. PubMed ID: 2476571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen.
    An LL; Whitton JL
    J Virol; 1997 Mar; 71(3):2292-302. PubMed ID: 9032365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch.
    Brown DM; Dilzer AM; Meents DL; Swain SL
    J Immunol; 2006 Sep; 177(5):2888-98. PubMed ID: 16920924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein.
    Kreil TR; Maier E; Fraiss S; Eibl MM
    J Virol; 1998 Apr; 72(4):3076-81. PubMed ID: 9525632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
    Lapham C; Golding B; Inman J; Blackburn R; Manischewitz J; Highet P; Golding H
    J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic T lymphocyte precursor cells specific for the major histocompatibility complex class I-like antigen, Qa-2, require CD4+ T cells to become primed in vivo and to differentiate into effector cells in vitro.
    Muraoka S
    Eur J Immunol; 1991 Sep; 21(9):2095-103. PubMed ID: 1679712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infection.
    Bongard N; Le-Trilling VTK; Malyshkina A; Rückborn M; Wohlgemuth K; Wensing I; Windmann S; Dittmer U; Trilling M; Bayer W
    PLoS Pathog; 2019 Sep; 15(9):e1008043. PubMed ID: 31568492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
    Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
    J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.